BUNKER KEVIN D. (Chief Operating Officer) sold 4.5% of their position (10K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $717.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 12/13/2021ACC: 0001725160-21-000238
Officer· Chief Operating Officer
Since Apr 2020
-10K
Net shares
Net seller
$717.1K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
10K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−434.00
Price / share
$70.29
Trade value
$30.50K
% of position
0.2%
12/10/2021
220K→219.57K
Common Stock
Indirect
Shares
−4.05K
Price / share
$71.17
Trade value
$288.15K
% of position
1.8%
12/10/2021
219.57K→215.52K
Common Stock
Indirect
Shares
−5.12K
Price / share
$72.10
Trade value
$368.95K
% of position
2.4%
12/10/2021
215.52K→210.40K
Common Stock
Indirect
Shares
−400.00
Price / share
$73.75
Trade value
$29.50K
% of position
0.2%
12/10/2021
210.40K→210K
Total
Net shares
−10K
Net value
-$717.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/10/2021 | S · Sale | −434.00 | $70.29 | $30.50K | 0.2% | 220K | 219.57K |
| Common Stock Indirect | 12/10/2021 | S · Sale | −4.05K | $71.17 | $288.15K | 1.8% | 219.57K | 215.52K |
| Common Stock Indirect | 12/10/2021 | S · Sale | −5.12K | $72.10 | $368.95K | 2.4% | 215.52K | 210.40K |
| Common Stock Indirect | 12/10/2021 | S · Sale | −400.00 | $73.75 | $29.50K | 0.2% | 210.40K | 210K |
| Total | −10K | -$717.11K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned755.07K
Common Stock
IndirectShares owned350.00
Total
755.07K direct·350.00 indirect755.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 755.07K | Direct |
| Common Stock | 350.00 | Indirect |
| Total | 755.42K | 755.07K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported